ANTIPSYCHOTIC POLYTHERAPY VERSUS ANTIPSYCHOTIC MONOTHERAPY IN PATIENTS WITH SCHIZOPHRENIA AND OTHER PSYCHOSES

被引：0
|
作者：
Morales Alcaide, N. [1 ]
机构：
[1] Hosp Nuestra Senora Perpetuo Socorro, Albacete, Spain
来源：
EUROPEAN PSYCHIATRY | 2011年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
P03-96
引用
收藏
页数：1
相关论文
共 50 条
  • [1] DIFFERENCES IN ANTIPSYCHOTIC COMBINATION (MONOTHERAPY VERSUS POLYTHERAPY) BETWEEN PATIENTS WITH SCHIZOPHRENIA AND PATIENTS WITH OTHER PSYCHOSES
    Morales, N.
    Diaz, M. C.
    Ruiz, J.
    Portela, M.
    Martinez, M. D.
    Ruiz, F. J.
    Lloret, J.
    Lucas, M.
    Mayordomo, A.
    Fraguas, D.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [2] Antipsychotic polytherapy versus monotherapy in specific dose categories in the maintenance treatment of schizophrenia
    Taipale, Heidi
    Taskanen, Antti
    Tiihonen, Jari
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 141 - 141
  • [3] Clinical correlates of antipsychotic polytherapy in patients with schizophrenia in Singapore
    Sim, K
    Su, A
    Chan, YH
    Shinfuku, N
    Kua, EH
    Tan, CH
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2004, 58 (03) : 324 - 329
  • [4] Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
    Fisher, Maxine D.
    Reilly, Kathleen
    Isenberg, Keith
    Villa, Kathleen F.
    BMC PSYCHIATRY, 2014, 14
  • [5] Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
    Maxine D Fisher
    Kathleen Reilly
    Keith Isenberg
    Kathleen F Villa
    BMC Psychiatry, 14
  • [6] Antipsychotic Monotherapy vs Polytherapy for Pneumonia Risk
    Kikuchi, Yuki
    Komatsu, Hiroshi
    Tomita, Hiroaki
    JAMA PSYCHIATRY, 2024, 81 (12) : 1277 - 1278
  • [7] Real-world effectiveness of antipsychotic monotherapy and polytherapy in 1543 patients with acute-phase schizophrenia
    Hatta, Kotaro
    Hasegawa, Hana
    Imai, Atsushi
    Sudo, Yasuhiko
    Morikawa, Fumiyoshi
    Katayama, Shigemasa
    Watanabe, Haruo
    Ishizuka, Takuya
    Nakamura, Mitsuru
    Misawa, Fuminari
    Fujita, Kiyoshi
    Ozaki, Shigeru
    Umeda, Kentaro
    Nakamura, Hiroyuki
    Sawa, Yutaka
    Sugiyama, Naoya
    ASIAN JOURNAL OF PSYCHIATRY, 2019, 40 : 82 - 87
  • [8] Antipsychotic monotherapy versus combination in schizophrenia: Are there differences in cognition?
    Ruiz, A.
    Branas, A.
    Vicens, M.
    Orozco, A.
    Lahera, G.
    EUROPEAN PSYCHIATRY, 2016, 33 : S277 - S278
  • [9] Antipsychotic Polypharmacy Versus Monotherapy in Elderly Patients with Chronic Schizophrenia: A Clinical Trial
    Mirabzadeh, Arash
    Shemshadi, Hashem
    Khodaei, Mohammad Reza
    Sadighi, Gita
    Hashempour, Sara
    Mirabzadeh, Hossein
    Biglarian, Akbar
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 24 (04): : 302 - 310
  • [10] Risperidone versus other atypical antipsychotic medication for schizophrenia
    William T. Carpenter
    Current Psychiatry Reports, 2000, 2 (5) : 375 - 375
12345